|
ZNF397 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.87140344624027E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.25300042248023E-10 |
| Normal-vs-Stage2 |
1.99290000058028E-08 |
| Normal-vs-Stage3 |
6.44462261334411E-12 |
| Normal-vs-Stage4 |
1.70770064755743E-11 |
| Stage1-vs-Stage2 |
6.313400E-01 |
| Stage1-vs-Stage3 |
2.841900E-02 |
| Stage1-vs-Stage4 |
4.823600E-02 |
| Stage2-vs-Stage3 |
2.852800E-01 |
| Stage2-vs-Stage4 |
3.466400E-01 |
| Stage3-vs-Stage4 |
9.543000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53269952285484E-10 |
| Normal-vs-AfricanAmerican |
6.41550000000102E-05 |
| Normal-vs-Asian |
1.59449999870276E-08 |
| Caucasian-vs-AfricanAmerican |
4.711200E-01 |
| Caucasian-vs-Asian |
7.740200E-01 |
| AfricanAmerican-vs-Asian |
6.329600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.13830081313904E-11 |
| Normal-vs-Female |
1.38389966153341E-10 |
| Male-vs-Female |
3.765600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.03130004536212E-09 |
| Normal-vs-Age(41-60Yrs) |
1.22860055462581E-10 |
| Normal-vs-Age(61-80Yrs) |
2.42510456160971E-11 |
| Normal-vs-Age(81-100Yrs) |
2.001700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.421800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.175750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.908210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.532600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.897800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.595800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.54109999999897E-05 |
| Classical-VS-Follicular |
3.553600E-02 |
| Classical-VS-Other |
6.149400E-01 |
| Classical-VS-Normal |
5.2487000301582E-09 |
| Tall-VS-Follicular |
7.640500E-02 |
| Tall-VS-Other |
4.400400E-01 |
| Tall-VS-Normal |
2.31581420706561E-12 |
| Follicular-VS-Other |
8.557000E-01 |
| Follicular-VS-Normal |
1.28219657113959E-11 |
| Other-VS-Normal |
6.095500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.9960036108132E-15 |
| Normal-vs-N1 |
4.320599988894E-09 |
| N0-vs-N1 |
8.727800E-01 |
|
|
